788328006: Polatuzumab vedotin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Mitotic inhibitor\Microtubule inhibitor\Polatuzumab vedotin

\Drug or medicament (substance)\Antineoplastic agent (substance)\Polatuzumab vedotin
\Drug or medicament (substance)\Monoclonal antibody\Polatuzumab vedotin

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Polatuzumab vedotin

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Polatuzumab vedotin

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Polatuzumab vedotin
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Polatuzumab vedotin
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Polatuzumab vedotin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3779936019 Polatuzumab vedotin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3779937011 Polatuzumab vedotin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3779936019 Polatuzumab vedotin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3779937011 Polatuzumab vedotin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Polatuzumab vedotin	Has disposition	Microtubule inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Polatuzumab vedotin	Is a	Microtubule inhibitor	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Polatuzumab vedotin	Is a	Monoclonal antibody	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Polatuzumab vedotin	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Polatuzumab vedotin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polatuzumab vedotin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polatuzumab vedotin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polatuzumab vedotin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polatuzumab vedotin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Polatuzumab vedotin only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polatuzumab vedotin	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets